Literature DB >> 1959703

Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats.

A Flyvbjerg1, K E Bornfeldt, H Orskov, H J Arnqvist.   

Abstract

Initial diabetic renal hypertrophy is preceded by a transient increase in kidney insulin-like growth factor I suggesting that insulin-like growth factor I may be implicated in diabetic kidney growth. The present study was undertaken to examine the effects of exogenous insulin-like growth factor I infusion on diabetic renal hypertrophy at a time when renal insulin-like growth factor I concentration had returned to normal and the initial steep kidney growth rate had diminished to a much slower rate. Groups of rats with diabetes duration of 5 days were infused s.c. for 4 subsequent days with equimolar concentrations of insulin-like growth factor I (36 nmol/day) or insulin (35 nmol/day). Insulin infusion lowered blood glucose to a normal level within 2 days and induced an average body-weight gain of 9.3 +/- 0.6 g/day. Insulin-like growth factor I infused diabetic rats maintained the original diabetic state with blood glucose levels comparable to those of 0.154 mol/l NaCl-infused diabetic rats, but had nevertheless an average body-weight gain of 6.8 +/- 1.0 g/day while untreated diabetic rats had a lower body-weight gain amounting to 3.3 +/- 0.8 g/day (p less than 0.01). The kidney weight at day 9 in untreated diabetic animals was about 25% greater than that of non-diabetic control animals, while in insulin-like growth factor I treated diabetic rats a further increase (p less than 0.05) was seen, amounting to 36% above control level. No increase was seen in the insulin-treated diabetic group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959703     DOI: 10.1007/bf00401516

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

Review 1.  Insulin-like growth factor-binding proteins (IGFBPs): more than just 1, 2, 3.

Authors:  G T Ooi
Journal:  Mol Cell Endocrinol       Date:  1990-06-18       Impact factor: 4.102

2.  Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.

Authors:  G S Tannenbaum
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

3.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E Futo; H Häsler; K Binz; H P Guler; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Identification of a type 1 insulin-like growth factor binding protein (IGF BP) in serum from rats with diabetes mellitus.

Authors:  T G Unterman; D T Oehler; R E Becker
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

5.  Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney.

Authors:  H Werner; Z Shen-Orr; B Stannard; B Burguera; C T Roberts; D LeRoith
Journal:  Diabetes       Date:  1990-12       Impact factor: 9.461

6.  Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues.

Authors:  K E Bornfeldt; H J Arnqvist; B Enberg; L S Mathews; G Norstedt
Journal:  J Endocrinol       Date:  1989-09       Impact factor: 4.286

7.  Renal hypertrophy in experimental diabetes mellitus.

Authors:  K Seyer-Hansen
Journal:  Kidney Int       Date:  1983-04       Impact factor: 10.612

8.  Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.

Authors:  S M Marshall; A Flyvbjerg; J Frystyk; L Korsgaard; H Orskov
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

9.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

10.  Regulation of insulin-like growth factor I gene expression by growth hormone.

Authors:  L S Mathews; G Norstedt; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  4 in total

1.  Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Milena Sochor; Murad Ali; Allan Flyvbjerg; Henning Grønbaek; Patricia McLean
Journal:  Int J Exp Pathol       Date:  2012-02       Impact factor: 1.925

2.  Identification of compounds that inhibit IGF-I signaling in hyperglycemia.

Authors:  Laura A Maile; Lee B Allen; Umadevi Veluvolu; Byron E Capps; Walker H Busby; Michael Rowland; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-01-06

3.  Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.

Authors:  J P New; J P Canavan; A Flyvbjerg; G Hamon; R W Bilous; S M Marshall
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

4.  Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats.

Authors:  Sirilaksana Kunjara; A Leslie Greenbaum; Patricia McLean; Henning Grønbaek; Allan Flyvbjerg
Journal:  Int J Exp Pathol       Date:  2012-06       Impact factor: 1.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.